S4181

SENATE, No. 4181

STATE OF NEW JERSEY

220th LEGISLATURE

INTRODUCED DECEMBER 4, 2023

 


 

Sponsored by:

Senator NELLIE POU

District 35 (Bergen and Passaic)

 

 

 

 

SYNOPSIS

Establishes Remote Methadone Dosing Pilot Program; appropriates $225,000.

 

CURRENT VERSION OF TEXT

As introduced.


An Act concerning opioid treatment programs, supplementing Title 26 of the Revised Statutes and making an appropriation.

 

Be It Enacted by the Senate and General Assembly of the State of New Jersey:

 

1. As used in this act:

Commissioner means the Commissioner of Human Services.

Department means the Department of Human Services.

Division means the Division of Mental Health and Addiction Services in the Department of Human Services.

Opioid treatment program means a program certified as an opioid treatment program by the federal Substance Abuse and Mental Health Services Administration and licensed to operate as an opioid treatment program in this State by the Department of Human Services.

Pilot program means the Remote Methadone Dosing Pilot Program established by this act.

Remote methadone dosing means the use of telehealth and telemedicine to remotely monitor a patients methadone-based treatment, which treatment is administered in the form of take-home doses of methadone.

 

2. a. The Department of Human Services shall establish a three-year Remote Methadone Dosing Pilot Program. The goal of the program will be: to increase the compliance of, and reduce the costs of providing, medication assisted treatment provided by participating opioid treatment programs through the use of remote methadone dosing; to evaluate the effect remote methadone dosing has on patient outcomes and cost-savings in the treatment of opioid use disorder; and to develop any recommendations for legislative or regulatory action concerning whether remote methadone dosing should be implemented in opioid treatment programs in this State.

b. The division shall select one opioid treatment program each in the cities of Atlantic City, Camden, and Paterson to participate in the pilot program.

c. In accordance with applicable federal and State laws and when clinically appropriate, each opioid treatment program participating in the pilot program shall be authorized to utilize remote methadone dosing to treat a patient who is receiving methadone-based treatment and is eligible to receive take-home doses of methadone. In treating patients using remote methadone dosing, participating opioid treatment programs shall utilize a provider of an online-enabled technology application, service, website, or system that facilitates remote methadone dosing approved by the department.

d. Under no circumstances shall the State or an opioid treatment program require that a patient participate in the pilot program.

e. Each opioid treatment program participating in the pilot program shall annually report to the department, in a manner prescribed by the commissioner, information on patient outcomes and cost-savings as a result of the pilot program, including information on:

(a) the number of patients treated using remote methadone dosing;

(b) treatment compliance;

(c) the average time each patient spends being treated using remote methadone dosing;

(d) patient retention;

(e) any realized reduction in medical transportation costs; and

(f) any other information the department deems relevant in evaluating the effectiveness of the pilot program.

 

3. The Department of Human Services shall, no later than four years after the date the program is established, prepare and submit to the Governor and, pursuant to section 2 of P.L.1991, c.164 (C.52:14-19.1) to the Legislature, a report that shall include:

a. an analysis on the impact of the pilot program on patient outcomes and cost-savings using the information collected pursuant to subsection e. of section 2 of this act;

b. any recommendations for legislative or regulatory action concerning the potential expansion of remote methadone dosing in opioid treatment programs in this State; and

c. any other information the department deems relevant in evaluating the effectiveness of the pilot program.

 

4. There is appropriated from the General Fund to the Department of Human Services the sum of $225,000 to implement the provisions of this act. The department shall issue a grant in the amount of $75,000 to each opioid treatment program selected to participate in the Remote Methadone Dosing Pilot Program to effectuate the provisions of this act.

5. The Commissioner of Human Services and the Commissioner of Health may each adopt rules and regulations, pursuant to the Administrative Procedure Act, P.L.1968, c.410 (C.52:14B-1 et seq.), as are necessary to implement the provisions of this act.

 

6. This act shall take effect 90 days after the date of enactment.

 

 

STATEMENT

 

This bill establishes the Remote Methadone Dosing Pilot Program in the Department of Human Services (DHS). The goal of the program will be: to increase the compliance of, and reduce the costs of providing, medication assisted treatment provided by participating opioid treatment programs (OTP) through the use of remote methadone dosing; to evaluate the effect remote methadone dosing has on patient outcomes and cost-savings in the treatment of opioid use disorder; and to develop any recommendations for legislative or regulatory action concerning whether remote methadone dosing should be implemented in opioid treatment programs in this State.

The bill defines remote methadone dosing to mean the use of telehealth and telemedicine to remotely monitor a patients methadone-based treatment, which treatment is administered in the form of take-home doses of methadone.

Under this bill, the Division of Mental Health and Addiction Services in the DHS will select one OTP each from the cities of Atlantic City, Camden, and Paterson to participate in the program. In accordance with applicable federal and State laws and when clinically appropriate, each OTP participating in the pilot program will be authorized to utilize remote methadone dosing to treat a patient who is receiving methadone-based treatment and is eligible to receive take-home doses of methadone. In treating patients using remote methadone dosing, participating OTPs will utilize a provider of an online-enabled technology application, service, website, or system that facilitates remote methadone dosing approved by the department. Under no circumstances will the State or an opi